|
Volumn 21, Issue 2, 2001, Pages 87-94
|
A double-blind comparison of lysine acetylsalicylate plus metoclopramide vs ergotamine plus caffeine in migraine: Effects on nausea, vomiting and headache symptoms
a b c d e |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMIGRAINE AGENT;
CAFERGOT;
LYSINE ACETYLSALICYLATE;
METOCLOPRAMIDE;
MIGPRIV;
PLACEBO;
ABDOMINAL PAIN;
ADULT;
ARTICLE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DYSPEPSIA;
FEMALE;
HEADACHE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALAISE;
MALE;
MIGRAINE;
MULTICENTER STUDY;
NAUSEA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SOMNOLENCE;
VERTIGO;
VOMITING;
|
EID: 0035089457
PISSN: 11732563
EISSN: None
Source Type: Journal
DOI: 10.2165/00044011-200121020-00001 Document Type: Article |
Times cited : (9)
|
References (15)
|